Abstract
The mechanism of the antitumoral effect of levan was studied in the C57BL mice-Lewis lung carcinoma system. Modulation of host immune response and a direct inhibitory effect on tumor cells were found. Local treatment was more effective when begun early. It reduced tumor incidence without affecting the size of developing tumors. Systemic treament was more effective when started late, inhibiting equally the tumor size in all mice. Macrophages are involved in local, lymphocytes possibly in systemic, inhibition. A direct effect on tumor cells was suggested by a decrease in oncogenicity, following preincubation with levan. Levan augments the antitumoral effect of cyclophosphamide in vivo and in vitro.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander P (1977) Innate host resistance to malignant cells not involving specific immunity. In: Day SB, Laird Myers WP, Stansly P,Garatini S, Lewis MG (eds) Progress in cancer research and therapy, vol 5. Raven, New York, pp 259–275
Apple MA (1978) New anticancer drug design: Past and future strategies. In: Becker FF (ed) Cancer, vol 5. Plenum, New York London, pp 599–652
Bekesi JG, St Arneault G, Holland JF (1971) Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Cancer Res 34:2130–2132
Bernacki R, Porter C, Korytnick W, Mihich E (1978) Plasma membrane as a site for chemotherapeutic intervention. Adv Enzyme Regul 16:217–237
Borit A, Leibovici J, Sandbank U, Sinai Y, Wolman M (1977) Inhibition of 3LL carcinoma of mice by levan treatment. Isr J Med Sci 13:859–869
Davies AM, Shilo M, Hestrin S (1955) The influence of Aerobacter levan on the permeability of the blood vessels of the skin: Studies with antibody globulins and trypan blue. Br J Exp Pathol 36:500–506
Flowers HM, Sharon N (1979) Glycosidases — properties and application to the study of complex carbohydrates and cell surfaces. Adv Enzymol 48:29–95
Hoenig S, Kazap I, Leibovici J (1978) Suppression of humoral immune response in mice by administration of high molecular levan. Experientia 34:1362–1363
Leibovici J, Sinai Y, Wolman M, Davidai G (1975) Effects of high-molecular levan on the growth and spread of lymphoma in AKR mice. Cancer Res 35:1921–1925
Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger JR, Hayat M, De Vassal F (1969) Active immunotherapy for acute lymphoblastic leukaemia. Lancet 1:697–699
Sezen E, Leibovici J, Wolman M (1978) Modification of the tuberculin reaction by levan. Br J Exp Pathol 59:454–456
Shilo M, Wolman M, Wolman B (1956) Inhibition of inflammatory response of skin to Staphylococcus aureus by high polymer levan. Br J Exp Pathol 37:219–221
Whistler RL, Bushway AA, Singh PP, Nakahara W, Tokuzen R (1976) Non-cytotoxic, antitumor polysaccharides. Adv Carbohydr Chem Biochem 32:235–275
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Leibovici, J., Stark, Y., Eldar, T., Brudner, G., Wolman, M. (1980). Mechanism of the Inhibitory Effect of Levan on Experimental Tumors. In: Mathé, G., Muggia, F.M. (eds) Cancer Chemo- and Immunopharmacology. Recent Results in Cancer Research, vol 75. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81491-4_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-81491-4_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81493-8
Online ISBN: 978-3-642-81491-4
eBook Packages: Springer Book Archive